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Abstract 
 
The reaction of DNA damaging agents with the genome results in a plethora of lesions, 
commonly referred to as adducts.  Adducts may cause DNA to mutate, they may represent the 
chemical precursors of lethal events, and they can disrupt expression of genes.  Determination of 
which adduct is responsible for each of these biological endpoints is difficult, but this task has 
been accomplished for some carcinogenic DNA damaging agents.  Here, we describe the 
respective contributions of specific DNA lesions to the biological effects of low molecular 
weight alkylating agents.   
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Introduction 
 
DNA damage can be caused by radiation, by organic and inorganic chemical agents and 
by enzymes that have the roles of promoting natural methylation and deamination, such as 
members of the S-adenosylmethionine  (SAM)-dependent methyltransferases, the activation 
induced deaminase (AID) and the apolipoprotein B editing complex (APOBEC) [1;2]. Because 
DNA is abundantly equipped with nucleophilic sites, reaction with extracellularly generated and 
endogenously produced electrophiles results in an amazingly diverse array of covalent chemical-
DNA adducts.  These lesions compromise cellular welfare in three major ways (Figure 1).  First, 
misreplication or misrepair of the lesions triggers mutations, which can be the initiating lesions 
of genetic diseases, including cancer.  Second, the lesions can jeopardize the epigenetic program 
imprinted by natural enzymatic DNA modifications.  Finally, the lesions can block RNA and 
DNA polymerases and can lead directly or indirectly to DNA strand breaks, which tend to be 
lethal in most cells.  The biological importance of DNA damage is evidenced by the large 
commitment of the genome to protection of informational integrity; such genoprotective 
networks include electrophile scavengers, recombination complexes that permit DNA lesion 
tolerance, specialized polymerases that afford lesion bypass, and a large battery of DNA repair 
proteins.  Loss of one or more of these networks results in loss of informational integrity and, 
ultimately, the onset of disease [1]. 
 
Once it was appreciated that DNA lesions cause mutagenic and toxic events, researchers 
sought to understand the relationships between the structure of each lesion in DNA and the 
biological endpoints indicated above [3].  For example, discovery of the mutagenic lesion of a 
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carcinogenic DNA damaging agent might lead to strategies to reduce the level of that lesion in 
DNA, and hence reduce the likelihood of carcinogenesis.  Studies on the DNA adducts of 
aflatoxin B1 led to intervention strategies at the population level that offer promise of reducing 
liver cancer burden [4].  As a second example, knowledge of the relationship between the 
structures of DNA adducts of anticancer drugs and cytotoxicity endpoints can aid drug 
development efforts in clinical pharmacology.  While it is obvious that establishing the 
relationships between DNA adducts and their biological endpoints is important, it proved very 
difficult to develop an experimental strategy to address the problem.  Even a single simple DNA 
damaging agent such as the aforementioned aflatoxin results in nearly a dozen DNA adducts, 
which frustrated early attempts to determine which adducts are the biologically important ones 
[5].   
 
Dissection of the relative biological importance of individual DNA lesions proved to be a 
tractable problem with the advent of methodology whereby investigators could place one lesion 
at a time into synthetic DNA (Figure 2).  In early in vitro studies, the oligonucleotides with 
adducts at known sites were acted upon with purified polymerases (Figure 2A) and repair 
proteins, which gave results that helped predict the biological relevance of a lesion and helped 
define the cellular repair systems that might protect against it.  A second step involved the use of 
shuttle vectors that were globally modified by a DNA damaging agent (Figure 2B).  Chemical or 
enzymatic tools allowed the mapping of some (but not all) lesion sites along a stretch of DNA.  
The damage spectrum was then compared to the spectrum of mutations that arose when the 
modified vector was replicated within cells.  Often multiple types of mutation were observed at a 
single site and it was impossible to ascertain if a single lesion gave rise to multiple mutations at, 
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for example, a guanine site, or whether there were several distinct guanine adducts each of which 
had its own signature and singular mutation.  Nevertheless, this approach was and continues to 
be a cornerstone of mutation research.   
 
The fusion of chemistry and biology, termed “chemical biology,” gave rise to a more 
advanced technology in which synthetic oligonucleotides containing well-characterized single 
DNA lesions were genetically engineered into the genomes of viruses or plasmids, which could 
be introduced into bacterial or mammalian cells (Figure 2C). Within the cell, the lesion would 
encounter the host repair and replication systems much in the same way that the lesion would be 
treated if it had formed endogenously.  Lethal endpoints could be measured as a decrease in viral 
or plasmid progeny.  Mutagenic outcomes could be determined by interrogating the vector 
genomes in the vicinity of the genomic site that originally contained the adduct.  The relative 
importance of various DNA repair and polymerase systems to deal with or process the adduct 
could be determined by introduction of the vector into cell strains with known defects in repair or 
replication.  In time, the quantitative and qualitative features of mutagenesis and toxicity of a 
wide array of DNA damaging agents were profiled by this new technology.  
 
This review examines in detail the application of a variety of experimental systems, 
primarily the use of site-specifically modified vector genomes, to categorize the mutagenic and 
toxic properties of DNA alkylating agents.  Such agents are common environmental carcinogens, 
some are formed endogenously and cause spontaneous DNA damage, and some have found use 
as cancer chemotherapeutic agents.  The paper specifically reviews current knowledge of the 
biological properties of each of the lesions formed by low molecular weight alkylating agents.  
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The structures of the relevant lesions are shown in Figure 3. By compiling data on lesion 
mutagenicity, genotoxicity and repairability, we develop a biological “fingerprint” for each 
lesion (Table 1).  It is noteworthy that some lesions have mutagenicities at or approaching 100%, 
whereas others display comparatively weak mutagenic properties; however, it must be kept in 
mind that a lesion with a mutagenicity of only 0.1% creates mutations at a rate that is five orders 
of magnitude greater than the basal or spontaneous rate of mutagenesis. In the review, exocyclic 
mono-adducts are covered first, followed by adducts in which endocyclic atoms are the points of 
attachment to the alkyl residue.  The final sections of the review cover small cyclic adducts.  To 
keep the manuscript of a manageable size, we have limited our attention to adducts of one or two 
carbon residues, avoiding larger adducts and some of the lipid-derived adducts that have been 
reviewed elsewhere [6].   
 
O6-Methylguanine and O6-ethylguanine 
O6-Methylguanine (O6MeG), which causes GA transitions [7], is the primary 
mutagenic lesion under most conditions of alkylation damage to the genome [8]. O6MeG is 
formed from both endogenous [9;10] and exogenous sources [11], and studies have correlated its 
persistence to organ-specific tumorigenicity in rats [12]. O6-Ethylguanine (O6EtG) is the major 
mutagenic lesion formed by ethylating agents [13] and also primarily causes GA transitions 
[14]. 
 
Escherichia coli has two O6-methylguanine-DNA-methyltransferases that can repair the 
adduct -- the constitutive Ogt protein and the inducible Ada protein, which directly reverse 
methylation damage by transferring the alkyl group to one of the internal cysteine residues on 
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each repair protein.  This transfer irreversibly inactivates the repair proteins, making the non-
enzymatic stoichiometric reaction “suicidal” [15]. Ada is part of the adaptive response, which 
was discovered when E. coli treated with a low dose of a methylating agent acquired resistance 
to the mutagenicity and toxicity of subsequent higher doses [16].  The alkyl groups from 
O6AlkGua and O4AlkThy are transferred to Cys 321 at the C-terminus, while those from a third 
substrate, methylphosphotriesters (MePT), are transferred to the N-terminus of Ada.  It was 
initially believed that the methyl group from MePT was transferred to Cys-69 on the protein [17] 
but recent evidence identifies Cys-38 as the acceptor residue [18]. Methylation of Cys-38 of Ada 
converts it to a transcriptional activator of the genes encoding the “adaptive response” to 
alkylating agents, namely, ada, alkA, alkB and aidB.  This is the most nucleophilic of all 
available cysteine residues in Ada since it is not part of a network of hydrogen bonds.  
Methylation at this site reduces the overall negative charge on Ada.  Reduction in charge density 
is important for the role of Ada as a transcription factor as it enhances its interaction with 
negatively charged DNA by 1000-fold [19]. The number of Ada molecules is estimated to rise 
from 1-2 molecules in an unadapted state to ~3000 molecules in a fully adapted cell [20;21]. It 
was initially found that Ada preferentially repairs O6MeG as compared to O4-methylthymine 
(O4MeT) [22] but recent evidence suggests it repairs both lesions with equal efficiency [23]. 
 
The second DNA methyltransferase, Ogt, was discovered by deletion of the ada operon 
[24;25]. Unlike Ada, Ogt is constitutively expressed in E. coli, shows a preference for repair of 
O4MeT and larger alkyl adducts, and does not repair MePT [25]. It is estimated that there are 
~30 molecules of Ogt in wild type E. coli [21]. The mammalian homolog of Ogt and Ada is 
MGMT (also referred to as AGT). This enzyme works in a similar suicidal fashion but is not 
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inducible, and it shows a 35-fold higher preference for repairing O6MeG over O4MeT [23]. 
Human MGMT can be silenced by epigenetic modifications [26]. This silencing plays a dual role 
in carcinogenesis as tumors not expressing MGMT acquire a mutator phenotype but also become 
more susceptible to killing by alkylating agents [27].  
 
Ogt is speculated to provide protection at low levels of sporadic exposure to alkylating 
agents, whereas the adaptive response becomes more important against higher chronic exposures 
or acute exposures that trigger the transcriptional switch of the adaptive response operon.  In 
addition to the methyltransferases, the UvrABC nucleotide excision repair (NER) pathway can 
also repair O6MeG.  Excision of O6MeG on duplex substrates has been shown to occur in vitro 
[28] and in vivo [29].  When O6MeG is present in a single-stranded context in vivo, NER does 
not affect mutation frequency of the lesion; the mutation frequencies in E. coli uvrB+ada−ogt− 
cells are very similar to those found in uvrB−ada−ogt− cells [30].  Interestingly, Chambers et al. 
found a 40 fold decrease in the GA transition caused by an O6MeG lesion introduced on a 
single-stranded ΦX174 genome in an NER deficient (uvrA) cell strain vs. wild type [31]. The 
authors suggest a shielding mechanism by which UvrA binds to the lesion and protects it from 
repair by Ada or Ogt, leading to elevated mutation frequencies.  There is some evidence of the 
NER pathway playing a role in repair of O6MeG in Drosophila melanogaster [32], and of O6EtG 
in D. melanogaster [33] and mammalian cells [34]. 
 
The mismatch repair (MMR) pathway has also been implicated in the cellular response to 
O6MeG [35]. O6MeG can be processed by post-replicative mismatch repair in E. coli in a 
double-stranded context, but in a single-stranded context (a gapped plasmid) the mutation 
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frequencies in wild type and mutS− cells are the same [36]. Using an M13 single-stranded system 
containing an O6MeG lesion, Rye et al. have shown that dam− and mutH− strains display the 
same mutation frequency as wild type, but mutS− and mutL− strains show a decrease [37].  This 
result suggests that MMR proteins may aid in the repair of O6MeG in a cooperative fashion. 
While early work suggested that O6EtG is not repaired by alkyltransferases or MMR in E. coli 
[38], more recent studies suggest that it is repaired by the same machinery that repairs O6MeG in 
mammalian cells [39].   Nevertheless, in rat mammary cells, O6EtG is repaired 20 times faster 
than O6MeG by an unknown, MGMT-independent, mechanism [40]. In line with expectations 
based upon this finding, a GA mutation is not seen as a frequent event at codon 12 of the H-ras 
gene in tumors initiated by N-ethyl-N-nitrosourea (ENU) compared to tumors initiated by N-
methyl-N-nitrosourea (MNU).   
 
The toxicity of O6MeG has been established by several studies, and it appears that 
abortive MMR or inhibition of replication systems may play roles in converting the adduct into 
lethal intermediates. Evidence that O6MeG is potently toxic in mammalian cells come from a 
number of studies, including those in MGMT knock-out mice, which display hypersensitivity to 
the lethal effects of alkylating agents that generate O6MeG [41]. There are two proposed 
mechanisms by which this lesion contributes to the toxicity generated by alkylating agents. The 
first suggests that the lesion reduces the efficiency of replication by polymerases. This 
phenomenon has been studied using in vitro systems. The rates of replication by T4 and T5 
phage DNA polymerases and E. coli polymerase I decrease linearly with increasing proportion of 
O6MeG in the synthetic oligonucleotide used as a template [42].  Also, human polymerase β, 
subcloned in an E. coli plasmid, is blocked by O6MeG present on a single-stranded DNA 
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template [43].  The second mechanism leading to toxicity is that of futile cycling of the 
mismatch repair system at an O6MeG:T pair [44;45].  The model proposes recognition of this 
base pair by the MMR enzymes, which results in the removal of the newly incorporated thymine 
from the nascent strand opposite the lesion.  On re-replication, O6MeG preferentially pairs once 
again with an incoming thymine [7], reinitiating the repair and replication cycle. This persistent 
iteration of excision and synthesis is thought to result in a stabilized nick or small gap in one 
strand of DNA, which may activate damage signaling pathways [46].  The recursive cycling 
mechanism is thought to be of practical significance in that it may explain the lethal effects of 
the anticancer drug, temozolomide [47].  In E. coli, O6EtG is more toxic than O6MeG [38] but 
the mechanism underlying this differential toxicity is unknown.   
 
O6MeG is known to be highly mutagenic.  To study the mutations formed in vivo, 
Loechler et al. constructed single-stranded M13mp8 DNA containing O6MeG at a specific 
position and transfected the same into E. coli.  It was found that the predominant mutation 
generated by this lesion was a GA transition.  In wild type E. coli, the lesion was weakly 
mutagenic, but challenging the Ada and Ogt repair systems of the cell by treatment with N-
methyl-N′-nitro-N-nitrosoguanidine (MNNG; which forms alkyl adducts in the host genome) 
resulted in a robust, dose-dependent demonstration of the mutagenic power of this adduct [7].  
This early study showed how significant even a few molecules per cell of a DNA repair protein 
could be as a protection against DNA damage.  The ethyl homolog of O6MeG, O6EtG, 
introduced at a specific position in ΦX174 and transfected into E. coli produces higher mutation 
frequencies compared to O6MeG in the same system [48;49].  O6MeG and O6EtG also have been 
site-specifically incorporated in Chinese hamster ovary cells and are shown to have a mutation 
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frequency of 19% and 11%, respectively, in cells lacking O6-alkylguanine-DNA alkyltransferase 
[50].  
 
A recent study used site-specific mutagenesis to generate single-stranded M13mp7 
genomes containing O6MeG in all sixteen possible permutations and combinations of nearest 
neighbor sequence contexts.  These genomes were then introduced into E. coli mutants of 
different repair backgrounds and the mutation frequencies were determined by a novel and very 
sensitive assay.  It was found that O6MeG went from being 10% mutagenic in repair-proficient 
cells to 100% mutagenic in repair-deficient cells [30].  Moreover, it was found that DNA repair 
in vivo is sequence context-dependent.   
 
With regard to effects on gene expression, O6MeG can inhibit carbon-5 methylation of 
cytosines in CpG motifs by interfering with the binding of 5-methylcytosine DNA 
methyltransferases; eventually this interference with natural methylation can lead to genome 
hypomethylation.  The pairing of O6MeG with thymine can also lead to DNA hypomethylation 
[51].  By these mechanisms, the formation of this adduct could affect the epigenetic program of 
mammalian cells.   
 
O4-Methylthymine 
O4MeT is one of the mutagenic lesions formed concurrently with O6MeG when DNA is 
exposed to alkylating agents that react with DNA by an SN1 mechanism. O4MeT is formed at a 
much lower level than O6MeG; for example, the methylated thymine was detected at a level 126 
times lower than that of O6MeG in calf thymus DNA treated with MNU [52].  Although it is not 
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an abundant lesion, O4MeT can be very mutagenic.  Using site-specific mutagenesis tools, it was 
shown that O4MeT incorporated in single-stranded M13mp19 had a mutation frequency of 12% 
in repair-proficient E. coli. O6MeG gave a mutation frequency of less than 2% in the same 
repair-proficient system.  Pretreatment with MNNG to deplete or occupy endogenous repair 
enzymes doubled this mutation frequency [53].  Similar results were obtained using double-
stranded and gapped plasmids in E. coli (mutation frequency of 45% for O4MeT vs. 6% for 
O6MeG) leading to the conclusion that O4MeT is much more mutagenic than O6MeG [38] on a 
mole-per-mole basis under normal conditions of DNA repair proficiency in cells.  O4MeT 
mimics cytosine in structure and generates an overwhelming majority of TC transitions [54]; it 
can also cause a small number of TA transversions in MMR deficient cells [39]. O4MeT has 
been examined as a site-specific adduct in mammalian vectors and again appears to be more 
mutagenic than O6MeG in both repair-proficient and repair-deficient backgrounds [39;55]. In E. 
coli, O4MeT is toxic but less so than O6MeG and O6EtG [38].  O4MeT has been shown to be 
toxic to mammalian cells deficient in NER capability [56], suggesting a role for this repair 
pathway in the cellular defense against this adduct.  
 
In E. coli, O4MeT is repaired by the same alkyltransferases that repair O6MeG. The Ogt 
protein from E. coli seems to have a preference for repair of O4MeT over O6MeG [25]. Ada 
repairs O6MeG and O4MeT with equal efficiency but human and rat alkyltransferases show a 
preference for O6MeG repair [23;57].  Studies in mammalian cells have shown that the mutation 
frequency of O4MeT does not vary significantly in the presence or absence of alkyltransferase, 
indicating that it is probably not repaired by MGMT [39;55]. In fact, mammalian 
alkyltransferases may actually inhibit repair of O4MeT by the NER pathway by binding to and 
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shielding the lesion, as evidenced in E. coli in studies using plasmids expressing human and 
mouse methyltransferases [58].  A study done in human cells lines using site-specifically 
modified plasmids containing O4MeT shows that repair is not influenced by the levels of 
alkyltransferase and that NER seems to be the most significant repair system for this lesion [56].  
With regard to repair by MMR, one in vitro study found that E. coli MutS (a DNA mismatch 
repair binding protein) does not bind to oligonucleotide-duplexes containing a site-specifically 
incorporated O4MeT:A base pair [35], while another shows that hMutSα, a protein of the MMR 
pathway in humans, recognizes and binds to a O4MeT:A base pair quite well but very poorly to 
an O4MeT:G base pair [59]. 
 
O2-Methylcytosine and O2-methylthymine 
O2-methylcytosine (O2MeC) and O2-methylthymine (O2MeT) are minor reaction 
products formed by treatment of DNA with alkylating agents such as MNU or MNNG.  Both 
lesions are repaired in vitro by E. coli AlkA [60].  O2MeC and O2MeT are predicted to interfere 
with minor groove contacts, yet there have been very few studies of these modifications, making 
the lesions good candidates for future study.   
 
Methylphosphotriesters 
Methylation damage can occur on the DNA sugar-phosphate backbone to form 
methylphosphotriesters (MePT).  The physical accessibility and negative charge of the phosphate 
oxygens makes them a favorable site for chemical reaction.  When double-stranded DNA is 
treated with MNU, 17% of the total methylation occurs on the backbone to yield 
methylphosphotriesters [13].  These adducts react with water and other nucleophiles much faster 
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than the common diester form of phosphate linking adjacent nucleosides, leading to facile 
cleavage of the backbone.  Of the two diastereomers formed, only the Sp-MePT is repaired by the 
Cys-38 residue in the N-terminal domain of Ada (N-Ada).  This selective repair results because 
the oxygen atom on the phosphate in the Sp diastereomer is only 3.5Ǻ away from the acceptor 
cysteine residue, vs. 5Ǻ in the Rp configuration [18]. As discussed earlier, N-Ada has an inherent 
electrostatic switch that works in a methylation-dependent fashion to modulate its affinity for 
DNA and ability to act as a transcription activator.  There is no known homolog of N-Ada in 
eukaryotes, thus making the repair of MePT in mammalian cells uncertain. 
 
In vivo studies using wild-type Ada and truncated Ada (lacking MePT repair capability) 
transfected into HeLa cells showed the same extent of resistance to the cytotoxic effects of 
alkylating agents, similar sister-chromatid exchange induction, as well as host-cell reactivation 
of adenovirus [61]. This observation suggests that MePT may not have cytotoxic effects in cells.  
The role of MePT seems to be a chemosensor for detection of methylation damage and induction 
of the adaptive response in E. coli, but their role, if any, in eukaryotes is unknown.   
 
N1-Methyladenine and N1-ethyladenine 
N1-Methyladenine (1MeA) is formed by alkylating agents mainly in single-stranded 
DNA and has been detected in vitro [62-68] and in vivo [64;69-72].  SN2 agents, such as 
methylmethanesulfonate (MMS) and the naturally occurring methyl halides can generate 1MeA 
[15]; similarly, the ethyl homolog, N1-ethyladenine (1EtA), is formed by ethylating agents both 
in vitro and in vivo [64].  The preference for formation in single-stranded DNA is owed to 
location of the N1 atom of adenine at a site usually protected by base pairing in double-stranded 
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DNA [73]. 1MeA is cytotoxic because it disturbs DNA replication [15]. 1-
Methyldeoxyadenosine is known to be unstable due to a base-catalyzed Dimroth rearrangement, 
a complex mechanism, the net result of which is the migration of the N1 methyl group to the 
exocyclic N6 position of adenine [74].  
 
A specialized DNA repair system protects cells from N1-substituted DNA lesions.  The 
AlkB enzyme of the adaptive response repairs 1MeA both in vitro and in vivo [75] in an 
oxidative reaction that liberates formaldehyde from the methylated base, affording complete 
reversal of the damage. The role of AlkB in the repair of 1MeA seems to be the prevention of 
genotoxicity, because this very toxic adduct is only weakly mutagenic in cells.  AlkB and its 
human homologs, ABH2 and ABH3, also repair 1EtA residues in DNA, with the release of 
acetaldehyde as the repair product [76].  Studies of 1MeA in vivo reveal that the lesion severely 
blocks DNA replication, but the replication block can be partially overcome by the induction of 
SOS bypass polymerases. The 1MeA blockade is completely removed in AlkB-proficient cells 
[75], underscoring the physiological relevance of the AlkB system for countering the toxicity of 
this base.  While very toxic, as indicated above, 1MeA is at best weakly mutagenic.  To the 
extent that it is mutagenic, 1MeA induces A to T mutations, which are enhanced following 
induction of the SOS polymerases. The base composition for A vs. T was respectively 99% vs. 
0.61% in SOS–/AlkB– cells, 99.7% vs. 0.06% in SOS–/AlkB+ cells, and 98.6% vs. 1.0% in 
SOS+/AlkB– cells [75]. 
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While the AlkB protein can repair the 1EtA lesion, it cannot repair 3-ethyladenine 
damage, which parallels AlkB’s activity on 1MeA but not on 3-methyladenine [76].  AlkB 
repairs 1EtA somewhat less well than 1MeA. 
 
N3-Methyladenine 
N3-Methyladenine (3MeA) can be formed in DNA by methylating agents as well as non-
enzymatically by intracellular SAM.  In a mammalian cell, SAM or some other methylating 
agent reacts with DNA to generate an estimated 600 3MeA per day [77].  The half life of 3MeA 
in vivo is estimated to be between 4-24 h [78].  While 3MeA is not particularly mutagenic, it is a 
cytotoxic DNA lesion by virtue of its ability to block replication or by virtue of its ability to give 
rise to a chemically- or enzymatically-generated abasic/apurinic site (AP site).  With regard to 
replication inhibition, it is thought that the methyl at the N3-position of purines sterically 
interferes with the required contact between the polymerase and minor groove on DNA [79]. 
This property makes it essential for the cell to have in place defenses against this form of 
damage. 3MeA-DNA-glycosylases have evolved in both prokaryotic and eukaryotic systems to 
afford the efficient repair this lesion. The prokaryotic system includes the highly selective and 
constitutive TAG protein, and the inducible AlkA glycosylase with a broader specificity. The 
eukaryotic system is comprised of alkylpurine-DNA-N-glycosylases (APNG) and human 3MeA-
DNA-glycosylase (AAG/ MPG). AlkA and TAG repair 3MeA with equal efficiency on double-
stranded DNA, but AlkA is 10-20 fold more efficient on single-stranded DNA [80]. There is also 
evidence that UvrA, an ATPase and DNA-binding protein of the NER pathway, may be able to 
mitigate the cytotoxic effects of this lesion.  One study used a neutral DNA equilibrium binding 
agent, Me-lex (N-methylpyrrolecarboxamide dipeptide (lex) modified with an O-methyl 
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sulfonate ester functionality), to introduce selectively 3MeA lesions in the minor groove of 
DNA.  It was shown that this agent shows increasing toxicity to E. coli mutants lacking one base 
excision repair (BER) repair enzyme (AlkA), two BER enzymes (AlkA and TAG), or both BER 
and NER repair capabilities (AlkA, TAG and UvrA), in that order [81].  
 
3MeA is not considered to be a seriously promutagenic lesion based upon work done in 
bacterial and in yeast systems.  In 3MeA-DNA-glycosylase I (tag) deficient E. coli mutants, 
treatment with MNU leads to a 5-fold increase in mutation frequency only under SOS-induced 
conditions.  Furthermore, in repair-proficient cells, removal of 3MeA from the DNA does not 
show a significant difference in mutagenesis in SOS-induced vs. SOS-uninduced cells [82].  To 
study the mutational profile of 3MeA in eukaryotic cells, the p53 gene cDNA on a yeast 
expression vector was treated with Me-lex in vitro and transfected into a yeast strain containing 
the p53-dependent reporter ADE2 gene. The results show that Me-lex is a weak mutagen 
compared with MNU, but that it induces A T transversions as the most common genetic 
change (40% of all mutations) [83].  Mutagenicity increased 2-3 fold in 3MeA-glycosylase 
deficient strains, which suggests that the lesion driving the mutations is 3MeA [84].  
Interestingly, the methylated adenines in Me-lex treated DNA give rise to mutations in a strictly 
sequence-specific manner.  
 
The cytotoxicity of 3MeA is well established in the literature. In vitro studies showing 
chain termination one nucleotide 3’ to adenines in methylated DNA templates pointed to 3MeA 
as a strong block to DNA replication. 3MeA in DNA has also been shown to be toxic in E. coli 
[81]. Using Me-lex in combination with 3-methyladenine-DNA-glycosylase proficient and 
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deficient cell lines, Engelward et al. showed that 3MeA can cause p53 induction, S phase arrest, 
sister chromatid exchange (SCE), chromosome aberrations, and apoptosis in mammalian cells 
[85]. As with 7MeG, enhanced repair of 3MeA by DNA glycosylases of the BER pathway can 
lead to a flood of AP sites that can also contribute to mutations and lethality [86]. 
 
N7-Methyladenine 
N7-Methyladenine (7MeA) is a minor lesion formed at a level 40-fold below that of 
7MeG, which is typically the most abundant lesion in alkylated DNA [87].  Like 7MeG, 7MeA 
possesses a cationic imidazole ring, which facilitates depurination and, alternatively, can favor 
hydrolysis of the five-membered ring to form the formamidopyrimidine derivative, Fapy-7MeA; 
this latter hydrolysis reaction is especially favored for the 7MeA in RNA [88], which has a 
stabilized glycosidic bond as compared to DNA.  The half life of 7MeA in DNA in vivo is only 
2-3 hours, which is similar to its half life in vitro at pH 7.2, 37 oC [89].  Fapy-7MeA is a 
mutagenic lesion, displaying AG transitions in single-stranded M13mp18 DNA transfected 
into SOS-induced E. coli [87;90].  In these studies, dimethylsulfate (DMS) treated DNA was 
compared before and after treatment with alkali, which hydrolyzed the imidazole rings of N7-
methylated adenines and guanines, forming the Fapy derivatives.  DMS and alkali treated DNA 
was 60-fold more mutagenic than DNA treated with DMS alone, and showed mutations 
primarily at A:T sites.   
 
N1-Methylguanine 
N1-Methylguanine (1MeG) has been found both in vitro [67] and in vivo [91]. With 
regard to biological relevance, the AlkB protein can repair 1MeG both in vitro and in vivo 
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[75;92].  The glycosylase AAG, which repairs 3MeA and a range of other lesions, is also active 
against 1MeG in vitro [93] but the in vivo relevance of AAG against this adduct has not been 
established as yet.  1MeG is a very strong block to replication, which can be partially overcome 
when the DNA lesion is partially repaired by AlkB; lesion bypass of 1MeG in vivo increases 8-
fold from 2% in AlkB– cells to 16% in AlkB+ cells.  Similarly, AlkB causes a reduction in the 
mutagenicity of 1MeG from a very high frequency of 80% in AlkB– cells to 4% in AlkB+ cells.  
Taken together these data indicate that AlkB is a powerful protection against the mutagenic 
activity of this dangerous alkylated base.  The mutational fingerprint of 1MeG reveals G T 
(57% of all progeny), G A (17%) and G C (6%) mutations.  In many instances, the 
induction of the SOS bypass polymerases results in increased bypass of a given lesion at the 
expense of reduced fidelity at the site of damage; however, the SOS polymerases are somewhat 
anti-mutagenic when they bypass this modified base [75]. 
 
N3-Methylguanine 
N3-Methylguanine (3MeG) is thought to block replication in the same way 3MeA does, 
but it is formed in DNA at a 15-fold lower level. The half-life of 3MeG in vivo has been shown 
to be 3 to 4 hours [89].  It has been shown that E. coli alkA mutants are sensitive to alkylating 
agents even though they express Tag [94], which repairs 3MeA (a known cytotoxic lesion) as 
efficiently as AlkA on double-stranded DNA [80]. This result suggests that 3MeG contributes to 
the toxic effects of alkylation seen in these cells.  
 
Using cell extracts from adapted E. coli, it was shown that the AlkA protein can repair 
3MeG present on methylated DNA in vitro. The same study also shows persistence of this adduct 
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in unadapted E. coli 30 min after exposure to MNNG [95]. A second in vitro study has shown 
that TAG also repairs 3MeG present on a synthetic GC rich double-stranded DNA sequence, 
albeit with an efficiency only 1/70th that of AlkA [96].   
 
N7-Methylguanine and its degradation products  
The N7 atom of guanine is the most chemically vulnerable site to attack by alkylating 
electrophiles as it has the highest negative electrostatic potential of all the other atoms within the 
DNA bases [97]. This property also makes it a highly reactive ligand for metal ions such as 
platinum [98].  When double-stranded DNA is treated with MMS or MNNG, 82% and 67% of 
the methylation occurs on the N7-position of guanine, respectively [13]. Within the cell, N7-
methylguanine (7MeG) is produced at the rate of 4000 residues/human genome/day by the non-
enzymatic reaction of SAM with DNA [77], and its steady-state level in repair-proficient cells is 
estimated to be 3000 bases [99].  7MeG has been detected in human DNA at the level of a few 
adducts per 107 bases [100]. 7MeG by itself does not have any major mutagenic or cytotoxic 
effects.  However, methylation at the N7-position destabilizes the N-glycosidic bond leading to 
spontaneous depurination of this lesion [101] and the resulting AP sites are toxic.  AP sites can 
also be formed during repair of 7MeG by N-alkylpurine DNA glycosylases which are part of the 
BER pathway. Although not examined directly in the context of alkylation, the mutagenic and 
toxic properties of AP sites have been thoroughly investigated [86]. 
 
In addition to its role as a source of AP-sites, 7MeG can manifest toxicity by converting 
to its imidazole ring-opened form. Hydrolysis of the imidazole ring of 7MeG forms 2,6-diamino-
4-hydroxy-5N-methyl-formamidopyrimidine (Fapy-7MeG). While this lesion does not cause 
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misparing with dAMP or dTMP, in vitro experiments using E. coli DNA polymerase I and poly 
(dGC) templates [102], or Klenow fragment and M13mp8 template DNA [103] show that Fapy-
7MeG blocks DNA chain elongation.  Fapy-7MeG lesions present on M13mp8 phage template 
DNA also leads to a 2-3 fold increase in GC and GT transversions when transfected into 
SOS induced E. coli [87].  However, DNA polymerase I preferentially incorporates dCMP 
opposite Fapy-7MeG and a Fapy-7MeG: C pair is extended most efficiently compared to other 
possibilities. This property makes Fapy-7MeG a lesion with weak mutagenic potential [88]. 
 
In E. coli, AlkA is known to excise 7MeG from methylated DNA [95]. In humans this 
reaction is carried out by AAG/MPG [104]. There exist specific DNA glycosylases in E. coli 
(formamidopyrimidine-DNA-glycosylase (Fpg)) and mammalian cells (human 7,8-dihydro-8-
oxoguanine DNA glycosylase (hOGG1)) [105] that remove Fapy-7MeG lesions.  E. coli Fpg 
repairs 7MeG very efficiently, with a Km in the nanomolar range [88]. It has been shown in a 
mammalian cell line by site-directed mutagenesis that overexpression of MPG sensitizes cells to 
alkylation damage by converting 7MeG into toxic AP sites, which lead to strand breaks.  7MeG 
by itself is not toxic to cells, nor is overexpression of MPG, but in combination they can 
overwhelm the cell with AP sites leading to cytotoxicity.  Rinne et al. propose that these two 
aspects combined with appropriate delivery systems could be exploited for the selective targeting 
of tumor cells, thereby reducing the peripheral effects of DNA damage by drugs [106].   
 
N3-Methylcytosine and N3-ethylcytosine  
N3-Methylcytosine (3MeC) is formed by SN2 agents such as MMS and the naturally 
occurring methyl halides [107] preferentially in single-stranded DNA.  It has been detected both 
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in vitro [62;64-68;108;109] and in vivo [64;70;71;91;109].  The corresponding ethyl homolog, 
N3-ethylcytosine (3EtC), is formed by ethylating agents in single-stranded DNA and also has 
been detected in vitro [64;65] and in vivo [64;110].  As with the 1-alkyladenines, these lesions 
likely exist only or predominantly in single-stranded DNA because this site of modification is 
normally protected by base pairing [73].  3MeC stalls DNA synthesis and is likely to be toxic 
[15]. 
 
In E. coli, the AlkB protein has good activity against 3MeC and 3EtC both in vitro and in 
vivo [62;63;75].  The appreciable mutagenesis and toxicity of the 3-alkylcytosines in vivo is 
decimated by AlkB, although a portion of the toxicity can also be overcome by induction of the 
SOS bypass polymerases.  With regard to mutagenic potential, if a cell has no AlkB and 
uninduced SOS bypass polymerases, 3MeC and 3EtC are 30% mutagenic, with the predominant 
mutations being C  T and C  A.  Basal expression of AlkB of a few molecules per cell 
abrogates the mutagenicity of 3MeC and 3EtC, whereas expression of SOS bypass polymerases 
in the absence of AlkB increases the mutagenicity of both lesions to a striking 70%.  Although 
investigations involving replication past 1MeA and N1-methylguanine (1MeG), which similarly 
have a blocked Watson-Crick hydrogen bonding face, by DNA polymerases in vitro are lacking, 
it is known from in vitro studies that 3MeC inhibits replication by DNA polymerase I and does 
not cause mutation [108;111;112]. However, some adduct bypass occurs with the incorporation 
of dAMP and dTMP opposite 3MeC [108].  Therefore, the rules for misreplication of the 3-
alkylcytosine lesions are the same both in vitro and in vivo, although the replicative system in 
cells is capable of a much higher mutation rate than is achieved in vitro [75;108].  
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N3-Methylthymine 
N3-Methylthymine (3MeT) has been found both in vitro [64;65;67;68;113] and in vivo [113;114] 
and is formed through the reaction of DNA with SN2 alkylating agents such as MMS.  This 
adduct is a very weak substrate for AlkB, and it is a strong block to replication in vivo, which can 
be only slightly overcome by SOS bypass polymerase induction [75]. Recently, FTO (fat mass 
and obesity associated) protein has been shown as a 2-oxoglutarate-dependent demethylase for 
nucleic acid [115;116]. FTO can efficiently repair 3MeT in single-stranded DNA but not in 
double-stranded DNA; it also shows strong activity on the demethylation of 3-methyluracil in 
single-stranded RNA [115;117]. While there are numerous epidemiological studies associating 
the FTO gene with obesity, the biological basis for metabolic effects of this gene are still under 
investigation. 
  
From the standpoint of its potential to induce genetic change, 3MeT is approximately 
60% mutagenic in SOS–/AlkB– cells, providing mostly T  A (47%) and T  C (9%) 
mutations.  Studies performed in vitro also show that 3MeT is a strong block to the Klenow 
fragment of DNA polymerase I, which slightly increases dTTP incorporation on a poly(dC-
d3MeT) template [118]; interestingly, T is exclusively incorporated opposite the analogous 3-
ethyldeoxythymidine adduct in one study [119], while A is exclusively incorporated in another 
[120]. 
 
8-Methylguanine 
C8-Alkylated DNA bases exist but have not been reported extensively in the literature.  
Recent studies have suggested that carbon-centered radicals can be a source of C8-alkylated 
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lesions.  8-Methylguanine (8MeG) was shown to be produced in vitro in RNA [121] and DNA 
[122] by methyl radicals generated by oxidation of 1,2-dimethylhydrazine and methylhydrazine 
respectively.  Proof of in vivo DNA alkylation by carbon-centered radicals was given by Netto et 
al. who detected 8MeG in DNA isolated from the liver and colon of rats administered 1,2-
dimethylhydrazine [123]. Other studies have shown that this lesion can also be produced in vitro 
and in vivo by genotoxic agents such as tert-butylhydroperoxide, diazoquinones and 
arenediazonium ions [124]. These findings are significant as they suggest a possible contribution 
of 8MeG in the carcinogenic effects of these agents, especially 1, 2-dimethylhydrazine, which 
induces adenocarcinomas of the colon in rodents.  
 
Site-specific studies using 8MedG-containing-oligonucleotides prepared by 
phosphoramidite synthesis have explored the mutagenecity and toxicity of this lesion.  It was 
found that 8MeG on the template strand blocks in vitro extension of DNA by mammalian 
polymerase α, but not by the E. coli Klenow fragment [125]. The products from the primer 
extension reaction were then analyzed for mutations. 8MeG was found to direct exo- Klenow 
fragment-based incorporation of dCMP most of the time (77%), but also paired occasionally with 
dGMP (1.1%) and dAMP (0.41%).  Similar numbers were obtained for extension assays with 
mammalian polymerase α. Replication with the Klenow fragment also introduced small amounts 
of one- (0.38%) and two- (0.81%) base-pair deletions [125]. These numbers mirror the 
thermodynamic stability of the 8MeG:dNMP base pair, decreasing in the order dCMP > dGMP > 
dAMP >> dTMP.  1,2-Dimethylhydrazine induces both O6MeG and 8MeG in similar amounts in 
the DNA of rats [123].  However, the mutation frequencies of 8MeG are two orders of 
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magnitude less than those of O6MeG [126]. Therefore, we may conclude that 8MeG is a weakly 
mutagenic lesion that in principle can contribute to G C transversions in cells. 
 
The repair of 8MeG has been studied in vitro by Gasparutto et al.  In this study, the 
authors incorporated 8MeG site-specifically into oligonucleotides and probed the ability of 
bacterial, yeast and mammalian glycosylases to repair this lesion. Of the extensive list of 
enzymes evaluated, only AlkA was able to excise 8MeG.  Human MPG did not repair 8MeG, 
nor did any of the glycosylases involved in repair of oxidative damage (Fpg, Nth of E. coli; 
Ntg1, Ntg2, Ogg1 of Saccharomyces cerevisiae; and human Ogg1) [124]. 
 
8MeG has been shown to stabilize the Z-conformation of DNA in short oligonucleotides 
even in low salt concentrations. This property may be relevant in vivo as Z-DNA is thought to 
have a role in the regulation of DNA supercoiling [127]. This lesion is also used as a chemical 
modification to stabilize qaudruplex structures of G-rich sequences of DNA, which are proposed 
to have a role in telomeric DNA stability and in repression of transcription at the c-myc promoter 
[128].  The wide range of potential biological activities of this lesion makes it a prime target for 
future investigations.   
 
1,N6-Ethenoadenine and 1,N6-ethanoadenine 
The formation of 1,N6-ethenoadenine (eA) results from the reaction of adenine with 
products of unsaturated lipid peroxidation [129-132]. This bifunctional DNA lesion arises 
endogenously under normal physiological conditions in both rodents and humans [133;134].  Of 
great toxicological concern is the observation that eA is induced by common industrial agent 
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vinyl chloride and its metabolites, such as chloroacetaldehyde.  eA also occurs in chronically 
inflamed human and rodent tissues [135]. Oxidative stress associated with inflammation is 
increasingly being linked to neurological disease, cancer promotion and accelerated aging [136].  
 
In duplex DNA, eA can be repaired in vitro by glycosylases of the BER pathway 
[93;137]. Mammalian cells can also repair etheno lesions by this route in vivo [138;139].  Indeed, 
the BER enzyme AAG and its homologs are likely to be the primary vehicles of repair of eA in 
the duplex genomes of eukaryotes.  By contrast, the in vivo repair of etheno adducts in E. coli 
was not clearly understood until recently; for example, one early study showed that neither BER 
nor NER figures prominently in etheno lesion repair [140].  Early genetic studies on the 
mutagenicity of eA in E. coli reinforced this conundrum [141]. The eA adduct was neither toxic 
nor mutagenic despite the fact that the base lacks any structural possibility of Watson-Crick 
complementarity.  The issues raised in these studies were resolved in 2005 when biochemical 
studies provided the possibility that the direct-reversal enzyme, AlkB, may play a significant role 
in the defense of cells against this type of bifunctional DNA damage.   These biochemical studies 
showed that AlkB and its human homolog ABH3 can efficiently repair eA in vitro [142;143].  
AlkB uses a unique iron-mediated biochemical reaction involving α-ketoglutarate as a cofactor 
to putatively epoxidize the exocyclic double bond of eA. An epoxide may be hydrolyzed to a 
glycol with the glycol moiety being liberated as the dialdehyde, glyoxal.  The direct reversal 
mechanism is also likely to be operative in vivo, as evidenced by genetic studies in which a 
single-stranded vector containing a single eA was replicated in AlkB proficient and deficient E. 
coli cells.  In AlkB-deficient cells, eA is 35% mutagenic, yielding 25% A T, 5% A G and 
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5% A C mutations.  SOS induction causes an increased incorporation of deoxyadenosine 
monophosphate opposite to eA [142]. 
 
1,N6-Ethanoadenine (EA) is the chemically reduced form of eA and forms through the 
reaction of adenine with the antitumor drug bis-chloroethylnitrosourea (BCNU).  EA can be 
weakly repaired by the E. coli enzyme AlkA [144] and the corresponding human enzyme AAG 
[93;145], which suggested that BER is a means of repair of this adduct.  Recent work, however, 
by Frick et. al. show that the direct-reversal repair enzyme AlkB easily alleviates the toxicity of 
EA in E. coli in vivo [146].  In an AlkB-proficient cell, EA is almost nontoxic (i.e., easily 
bypassed) and not significantly mutagenic.  However, in AlkB-deficient cells, EA is extremely 
toxic, showing an 86% reduction in replication. The adduct is weakly mutagenic causing A C 
(2%), A G (1%), and A T (1%) mutations [146]. 
 
1,N2-Ethenoguanine and 3,N2-ethenoguanine 
1,N2-Ethenoguanine (1,2-eG) and its isomer 3,N2-ethenoguanine (2,3-eG) are cyclic DNA 
adducts formed, as with eA, by reagents such as chloroacetylaldehyde [147] or 4-hydroperoxy-2-
nonenal (HPNE) [148].  Significantly, the former has been found in the liver DNA of rodents 
exposed to vinyl chloride [147]. 1,2-eG can moderately block DNA polymerase and cause GT 
and GC base substitutions, as well as frameshift mutations [149].  It can be repaired by 
mammalian uracil-DNA-glycosylase (MUG) and AAG [93;150].  In recent work, 1,2-eG, was 
shown to be repaired, albeit weakly, by BER, using a truncated form of the AAG enzyme [93].  
The AlkA protein can release 2,3-eG from DNA [151].  The glycosidic bond of 2,3-eG is 
extremely labile, a property that has made assessment of biological significance of this modified 
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base a difficult task [147].  Nevertheless, Loeb and colleagues successfully determined the 
mutation frequency of the lesion to be approximately 13% in E. coli, where it primarily induces 
G A transitions.  
 
3,N4-Ethenocytosine  
  3,N4-Ethenocytosine (eC) is produced from the same precursors and by the same 
pathways that generate eA in DNA [129-131;152].  As with eA, the BER pathway (human 
thymine-DNA-glycosylase (hTDG) in human and double-stranded uracil-DNA-glycosylase 
(dsUDG) in E. coli) is an established strategy used by nature to suppress the biological effects of 
this adduct [138;152].  The cellular defense network against eC additionally involves the AlkB 
pathway, at least in E. coli., which should be mechanistically similar to that of eA repair by AlkB 
[142].  In E. coli, AlkB has a modest effect on eC toxicity, but reduces the mutation rate of the 
adduct by about two-thirds from 82% in AlkB-deficient cells to 37% in AlkB-proficient hosts, 
implying incomplete conversion to cytosine prior to polymerase traversal.  The mutations of eC 
in AlkB-deficient and -proficient cells are C A and C T, which are of approximately equal 
abundance in each cellular background.    
 
Perspective 
Thirty years ago, when Carcinogenesis was a new Journal, the field of cancer research 
looked very different from the way it looks today.  The field was richly populated by chemists 
who identified carcinogens and studied the molecular transformations whereby those agents 
damaged DNA.  The work described in this review started shortly after the Journal began, when 
the complexities of DNA adduction confounded attempts to relate specific types of DNA damage 
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with genetic changes that, presumably, attend the conversion of a normal cell into a fully 
malignant one.  From that time to the present, much has been learned.  Many oncogenes and 
tumor suppressor genes have been discovered and placed like footsteps on the path between 
normalcy and malignancy [153].  More recently, linkages have been made between the genetic 
events of oncogene activation and tumor suppressor gene inactivation and parallel disruptions in 
biochemical networks.  These studies are revealing the secrets of how cancer cells obtain the 
energy and the raw materials to finance their growth into a tumor [154;155].  One revelation to 
come out of the last few decades is that the number of mutations in cancers is far in excess of the 
number one would expect on the basis of normal replication errors, or perhaps even the enhanced 
rate of replication errors that occurs when a polymerase tries to copy past a mutagenic DNA 
lesion such as those described in this manuscript.  While it seems likely that genetic changes 
induced by carcinogens are an important step in the early stage of malignant transformation, it 
now seems clear that we need to find other chemical or biochemical events that underpin the 
“mutator phenotype” of tumors [156].  Answers may come from studies of virally induced 
diseases, such as HIV and hepatitis, where recent work has discovered enzymatic DNA-targeted 
base deamination systems that cause a high density of mutations within a genome [157].  
Answers might also come from the field of immunology where enzymes such as AID cause, 
once again, a high density of mutations in a localized stretch of DNA [158;159].   
 
One of the most important contributions of work on the chemical biology of mutagenesis 
has been the collateral impact of this field on the nearby field of DNA repair.  It is now common 
for workers in the repair field to use oligonucleotides with single lesions, originally made for 
studies of mutagenesis, to characterize the detailed biochemical mechanisms by which repair 
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enzymes or complexes reverse the damage.  Moreover, studies of mutagenesis done using cells 
that are defective in a specific repair enzyme [142] or that express specialized polymerases [160] 
have provided high quality data that have established the physiological relevance of specific 
enzymes as protectors from damage, or as the vehicles by which damage is processed into events 
with disastrous consequences for the cell and organism.   
 
Looking ahead, there is much to do.  To give one example, the process of inflammation is 
clearly associated with cancer development [136].  The range of DNA damages created by 
inflammation-generated reactive oxygen and nitrogen species is vast, and the task will be a large 
one to determine how each of these lesions contributes to the biological endpoints downstream of 
an inflammatory event.  As a second example, workers will soon develop modified versions of 
the tools described herein to probe what may become a new field … RNA repair.  Some mRNA 
species are so long that it takes a day to transcribe them [161-163].  These important molecules 
not only need to have their informational integrity protected, but the energy used in their 
synthesis is large and would be wasted if a single lesion, for example an eA residue, made them 
un-readable.  Finally, while this review focuses on only one class of lesion, the small alkylated 
bases, it illustrates how much can be learned about the chemical rules of mutagenesis.  Ten years 
ago, studies of the mutagenic properties of 5-hydroxycytosine [164], which induces C to T 
transitions, were the starting point for a novel application in the development of antiviral agents 
[165].  It is expected that additional examples of this nature, in which basic studies of 
mutagenesis drive clinical development, will help propel this field into a robust future.   
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Tables 
Table I. Mutagenicity, genotoxicity and repairability of DNA alkylation lesions. 
Lesion Mutagenic  
specificity 
Genotoxicity Repaired by  
prokaryotic 
enzymes/systems 
Repaired by  
eukaryotic 
enzymes/systems 
O6MeG G A Toxic in presence of 
MMR 
Ada, Ogt 
UvrABC (NER) 
MMR 
MGMT 
NER 
MMR 
O6EtG G A Toxic in E.coli Not repaired by  
Ada or Ogt 
MGMT 
NER 
MMR 
O2MeC  Possibly toxic   
O2MeT  Possibly toxic   
O4-MeT T C  
T A in MMR- 
deficient cells 
Toxic, but less than 
O6MeG and O6EtG 
in E.coli 
Ada, Ogt NER  
MGMT 
(minimal) 
 
MePT  None known None known Ada  
1MeA  A T Mutagenic and toxic 
to E. coli in the 
absence of AlkB 
 
AlkB AAG 
ABH2, ABH3 
1EtA  Mutagenic and toxic 
to E. coli in the 
absence of AlkB 
AlkB ABH2, ABH3 
3MeA A T  Highly toxic AlkA 
Tag 
UvrA 
AAG/ 
APNG/ 
MPG 
7MeA Fapy-7MeA 
A G  
   
1MeG G T  
G A  
G C  
Mutagenic and toxic 
to E. coli in the 
absence of AlkB 
AlkB AAG 
3MeG  Possibly toxic  AlkA 
Tag 
 
7MeG Fapy-7MeG 
G C 
G T 
Toxic via formation 
of AP sites and Fapy-
7MeG 
AlkA 
Fpg 
AAG/ 
MPG 
hOGG1 
3MeC C T 
C A 
Toxic AlkB AAG 
ABH2, ABH3 
3EtC C T 
C A 
Toxic AlkB  
3MeT AlkB deficient cell 
T A  
Strong block to 
replication 
Weak substrate  
for AlkB 
FTO 
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T C  
8MeG G C  AlkA Not repaired  
by known  
enzymes 
eA  AlkB deficient cell 
A T  
A G  
A C  
Mutagenic and toxic 
to E. coli in the 
absence of AlkB 
AlkA 
AlkB 
AAG 
EA A T (weak) 
A C (weak) 
A G (weak) 
Toxic to E. coli in 
the absence of AlkB 
AlkB 
Weak substrate 
for AlkA 
AAG 
1,2-eG G T 
G C 
Mutagenic and 
causes frameshift 
MUG AAG 
2,3-eG G A Mutagenic AlkA  
eC C A 
C T 
Mutagenic and toxic 
to E. coli in the 
absence of AlkB 
AlkB 
dsUDG 
hTDG 
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Legends to Figures 
 
Fig. 1.  Pathways by which DNA damaging agents induce biologically relevant events.  Agents 
from the environment, chemically reactive natural species generated within cells, and the 
misdirected action of natural intracellular enzymatic systems can result in the formation of a 
collection of DNA lesions (symbols attached to the helix).  These lesions can be formal 
chemical-DNA adducts, such as O6MeG, which is a miscoding lesion during replication.  They 
can be modifications of the sugar-phosphate backbone, such as MePT, which triggers a change in 
gene expression.  They can be bases such as uracil, which can appear as the enzymatic 
deamination product of cytosine.  Or, they can be lethal strand breaks, as would form after 
treatment of a cell with ionizing radiation or certain anticancer agents.  Finding the relationships 
between the structures of each lesion and the biological endpoints of mutation, lethality and gene 
expression is the subject of this review. 
 
 
Fig. 2.  A.  Methods to evaluate the biological relevance of DNA damage.  The ability of a DNA 
lesion (lollipop structure) to block polymerases in vitro and cause mispairing during DNA 
synthesis can be evaluated in a system in which a template containing the lesion is primed with a 
complementary oligonucleotide that terminates to the 3’ side of the lesion.  DNA synthesis may 
result in incorporation of non-complementary bases or in truncated products, which can be 
evaluated on sequencing gels.  The same in vitro constructs, in double-stranded or single-
stranded form, can also be used as substrates for DNA repair reactions, using purified DNA 
repair proteins or cellular extracts.  B.  To determine the mutagenic properties of the full 
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population of adducts that forms from treatment of DNA with a mutagen, a plasmid or viral 
vector is treated with the damaging agent.  Replication of the vector in cells results in repair of 
some adducts but those that evade repair can possibly be converted into mutations.  Sequencing 
the genomes of progeny can generate the mutational spectrum, which indicates the types and 
frequencies of specific mutations along the DNA sequence being studied.  In parallel, one can 
map the locations of some of the DNA adducts by using enzymatic or chemical probes.  The 
corresponding damage spectrum is often compared with the mutational spectrum in order to 
formulate hypotheses with regard to which DNA adduct might have caused specific mutations.  
C.  The most sophisticated system for analysis of mutagenesis involves chemical or enzymatic 
synthesis of an oligonucleotide that contains a candidate for mutagenesis (often the candidate is 
nominated based on the data from experiments shown in part B).  The oligonucleotide is inserted 
into the genome of a virus or plasmid, which is later replicated within cells, either intra- or extra-
chromosomally.  Progeny are analyzed to determine the type, amount and genetic requirements 
for mutagenesis by the lesion.  In parallel, the reduction in viable progeny is determined as an 
estimate of the extent to which each lesion inhibits replication of the genome. 
 
 
Fig. 3. Structures of DNA alkylation lesions. 
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